COVID‐19 in pregnant women and children: Insights on clinical manifestations, complexities, and pathogenesis

Pregnancy changes the body's immune system to counteract the spectrum of infections, including COVID‐19, which can pose complications. Pregnant women are less likely to contract COVID‐19 infections than the general public. However, pregnant women are at slightly increased risk of becoming severely unwell if they do catch COVID‐19, and congenital conditions in pregnant women may worsen the state of infection and lead to critical stages and even mortality. The possibility of vertical transmission has been reported in only a few cases of COVID‐19; however, it was not noted in cases of SARS and MERS. Vaccination coverage in pregnant women remains a challenge. Children are the next suspected and vulnerable population to acquire infection after the first and second waves. Children are disproportionately infected compared with older populations, but the severity of infection is less compared to adults. This review highlights the complexities of COVID‐19 in pregnant women and the underlying reasons why children tend to be comparatively less severely affected. Ethnicity, nutrition, lifestyle, and therapeutics influence the severity of infection in children. Low expression of angiotensin‐converting enzyme 2 receptors, indigenous virus competence, and maternal immunity is the first‐line defense for children against COVID‐19. Habituating herbal medicines from childhood may help support a robust and defensive immune system to counteract novel antigens and encourage healthy generations. Identifying and protecting susceptible populations, such as pregnant women and newborns, against COVID‐19 is critical.